Maryland HB1121 establishes an advisory council to evaluate and recommend policies for perimenopausal, menopausal, and postmenopausal conditions.

Maryland HB1121 creates an advisory council to evaluate opportunities for state policy initiatives that improve the health and economic security of individuals with perimenopausal, menopausal, and postmenopausal conditions. The council will report its findings and recommendations to the General Assembly by October 1, 2027. The Maryland Health Care Commission, the Maryland Commission for Women, and the Maryland Department of Health are required to evaluate methods for increasing clinical education and access to health care services for these conditions, with reports due by October 1, 2027.

Maryland HB1121 establishes an advisory council to evaluate and recommend policies for perimenopausal, menopausal, and postmenopausal conditions.

Maryland HB1121 creates an advisory council to evaluate opportunities for state policy initiatives that improve the health and economic security of individuals with perimenopausal, menopausal, and postmenopausal conditions. The council will report its findings and recommendations to the General Assembly by October 1, 2027. The Maryland Health Care Commission, the Maryland Commission for Women, and the Maryland Department of Health are required to evaluate methods for increasing clinical education and access to health care services for these conditions, with reports due by October 1, 2027.